Factors affecting participation in a breast cancer risk reduction telephone survey among women from four racial/ethnic groups

Preventive Medicine

Volumn 41, Issue 3-4, 2005, Pages 720-727

  Des Jarlais, Genevieve ^a   Kaplan, Celia Patricia ^a   Haas, Jennifer S ^b   Gregorich, Steven E ^a   Pérez Stable, Eliseo J ^a   Kerlikowske, Karla ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African Americans; Asian Americans; Behavioral research; Breast cancer; Epidemiologic studies; Hispanic Americans; Patient participation; Prevention; Surveys; Whites

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDUCATION; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HIGH SCHOOL; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MINORITY GROUP; NEGRO; PRIORITY JOURNAL; RISK REDUCTION; TELEPHONE;

ADULT; AGED; BREAST NEOPLASMS; CONSUMER PARTICIPATION; DATA COLLECTION; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SAN FRANCISCO;

EID: 25844489137     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2005.04.001     Document Type: Article

References (45)

1. A.S. Advani, B. Atkeson, C.L. Brown, B.L. Peterson, L. Fish, and J.L. Johnson Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study Cancer 97 2003 1499 1506
2. G.A. Alexander, K.C. Chu, and R.C. Ho Representation of Asian Americans in clinical cancer trials Ann. Epidemiol. 10 2000 S61 S67
3. R. Ballard-Barbash, S.H. Taplin, B.C. Yankaskas, V.L. Ernster, R.D. Rosenberg, and P.A. Carney Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database AJR Am. J. Roentgenol. 169 1997 1001 1008
4. D.R. Brown, and M. Topcu Willingness to participate in clinical treatment research among older African Americans and Whites Gerontologist 43 2003 62 72
5. S.M. Chang, F.G. Barker II, M.H. Schmidt, A.E. Sloan, R. Kasper, and L. Phillips Clinical trial participation among patients enrolled in the Glioma Outcomes Project Cancer 94 2002 2681 2687
6. G. Corbie-Smith, S.B. Thomas, and D.M. St. George Distrust, race, and research Arch. Intern. Med. 162 2002 2458 2463
7. G. Corbie-Smith, D.M. St. George, S. Moody-Ayers, and D.F. Ransohoff Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities J. Clin. Epidemiol. 56 2003 416 420
8. G. Corbie-Smith, C.M. Viscoli, W.N. Kernan, L.M. Brass, P. Sarrel, and R.I. Horwitz Influence of race, clinical, and other socio-demographic features on trial participation J. Clin. Epidemiol. 56 2003 304 309
9. D.D. Dunlop, L.M. Manheim, J. Song, and R.W. Chang Gender and ethnic/racial disparities in health care utilization among older adults J. Gerontol. B Psychol. Sci. Soc. Sci. 57 2002 S221 S233
10. P.M. Ellis, P.N. Butow, M.H. Tattersall, S.M. Dunn, and N. Houssami Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate J. Clin. Oncol. 19 2001 3554 3561
11. B. Fisher, J.P. Costantino, D.L. Wickerham, C.K. Redmond, M. Kavanah, and W.M. Cronin Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90 1998 1371 1388
12. M.H. Gail, and J. Benichou Validation studies on a model for breast cancer risk J. Natl. Cancer Inst. 86 1994 573 575
13. M.H. Gail, L.A. Brinton, D.P. Byar, D.K. Corle, S.B. Green, and C. Schairer Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J. Natl. Cancer Inst. 81 1989 1879 1886
14. Geographical mobility March 1999 to March 2000, 2001. United States Census: U.S. Bureau of the Census.
15. A.T. Geronimus, and J. Bound Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples Am. J. Epidemiol. 148 1998 475 486
16. A.R. Giuliano, N. Mokuau, C. Hughes, G. Tortolero-Luna, B. Risendal, and R.C.S. Ho Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors Ann. Epidemiol. 10 2000 S22 S34
17. J.L. Hargraves, P.J. Cunningham, and R.G. Hughes Racial and ethnic differences in access to medical care in managed care plans Health Serv. Res. 36 2001 853 868
18. Y. Harris, P.B. Gorelick, P. Samuels, and I. Bempong Why African Americans may not be participating in clinical trials J. Natl. Med. Assoc. 88 1996 630 634
19. V.L. Holt, D.P. Martin, and J.P. LoGerfo Correlates and effect of non-response in a postpartum survey of obstetrical care quality J. Clin. Epidemiol. 50 1997 1117 1122
20. Y.A. Hundrup, H. Thoning, E.B. Obel, N.K. Rasmussen, and J. Philip Lifestyle factors and choice of hormone replacement therapy among Danish nurses Scand. J. Public Health 30 2002 47 53
21. M. Killien, J.A. Bigby, V. Champion, E. Fernandez-Repollet, R.D. Jackson, and M. Kagawa-Singer Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health J. Womens Health Gend. Based Med. 9 2000 1061 1070
22. L.T. Kozlowski, G.P. Vogler, D.J. Vandenbergh, A.A. Strasser, R.J. O'Connor, and B.A. Yost Using a telephone survey to acquire genetic and behavioral data related to cigarette smoking in "made-anonymous" and "registry" samples Am. J. Epidemiol. 156 2002 68 77
23. E. Loekkegaard, L.F. Eplov, A. Koster, and K. Garde Description of women's personality traits and psychological vulnerability prior to choosing hormone replacement therapy Arch. Women Ment. Health 5 2002 23 31
24. C.R. McCarthy Historical background of clinical trials involving women and minorities Acad. Med. 69 1994 695 698
25. P.G. Moorman, B. Newman, R.C. Millikan, C.K. Tse, and D.P. Sandler Participation rates in a case-control study: the impact of age, race, and race of interviewer Ann. Epidemiol. 9 1999 188 195
26. NCI Breast Cancer Risk Assessment Tool: http://bcra.nci.nih.gov/brc/ ; 2000.
27. R.B. Ness, D.B. Nelson, S.K. Kumanyika, and J.A. Grisso Evaluating minority recruitment into clinical studies: how good are the data? Ann. Epidemiol. 7 1997 472 478
28. NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research: http://grants.nih.gov/grants/guide/notice-files/not94-100. html ; 1994.
29. Profile of General Demographic Characteristics. United States Census 2000 2000 U.S. Bureau of the Census
30. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity-United States, 1990-1998, 2002. MMWR Morb. Mortal. Wkly. Rep. 51, 49-53.
31. M.A. Richardson, J. Post-White, S.E. Singletary, and B. Justice Recruitment for complementary/alternative medicine trials: who participates after breast cancer Ann. Behav. Med. 20 1998 190 198
32. B.K. Rimer, J.M. Schildkraut, C. Lerman, T.H. Lin, and J. Audrain Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium Cancer 77 1996 2348 2355
33. N.L. Roberson Clinical trial participation. Viewpoints from racial/ethnic groups Cancer 74 1994 2687 2691
34. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
35. SEER Cancer Statistics Review, 1975-2000 2003 National Cancer Institute Bethesda, MD
36. V.L. Shavers, C.F. Lynch, and L.F. Burmeister Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies J. Natl. Med. Assoc. 92 2000 563 572
37. V.L. Shavers, C.F. Lynch, and L.F. Burmeister Factors that influence African-Americans' willingness to participate in medical research studies Cancer 91 2001 233 236
38. V.L. Shavers, C.F. Lynch, and L.F. Burmeister Racial differences in factors that influence the willingness to participate in medical research studies Ann. Epidemiol. 12 2002 248 256
39. V.L. Shavers-Hornaday, C.F. Lynch, L.F. Burmeister, and J.C. Torner Why are African Americans under-represented in medical research studies? Impediments to participation Ethn. Health 2 1997 31 45
40. Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS report no. 7 Control Clin. Trials. 22 2001 526 537
41. SPSS for Windows 2001 SPSS Inc. Chicago
42. T. Strinic, D. Bukovic, D. Karelovic, A. Despot, N. Bukovic, and E. Giudici Socio-demographic characteristics of postmenopausal estrogen users Coll. Antropol. 26 2002 245 249
43. H.A. Tejeda, S.B. Green, E.L. Trimble, L. Ford, J.L. High, and R.S. Ungerleider Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials J. Natl. Cancer Inst. 88 1996 812 816
44. V.G. Vogel, J.P. Costantino, D.L. Wickerham, W.M. Cronin, and N. Wolmark The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial Clin. Breast Cancer 3 2002 153 159
45. L.F. Voigt, T.D. Koepsell, and J.R. Daling Characteristics of telephone survey respondents according to willingness to participate Am. J. Epidemiol. 157 2003 66 73